Compare NGL & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NGL | LMAT |
|---|---|---|
| Founded | 1940 | 1983 |
| Country | United States | United States |
| Employees | 569 | N/A |
| Industry | Natural Gas Distribution | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | N/A | 2006 |
| Metric | NGL | LMAT |
|---|---|---|
| Price | $15.49 | $92.65 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $105.80 |
| AVG Volume (30 Days) | ★ 271.3K | 238.2K |
| Earning Date | 05-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 0.68 |
| Revenue | N/A | ★ $249,602,000.00 |
| Revenue This Year | N/A | $14.21 |
| Revenue Next Year | N/A | $8.88 |
| P/E Ratio | $366.01 | ★ $137.34 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $3.95 | $79.01 |
| 52 Week High | $18.80 | $118.01 |
| Indicator | NGL | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 46.23 | 39.29 |
| Support Level | $15.12 | $82.26 |
| Resistance Level | $18.80 | $97.83 |
| Average True Range (ATR) | 0.86 | 2.65 |
| MACD | -0.14 | 0.39 |
| Stochastic Oscillator | 25.43 | 35.96 |
NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.